Whitepapers
Pharma white papers on contemporary issues, technologies, research, etc. are presented in this section to enable the readers with rich information and knowledge. This section provides white papers related to all the spheres of the pharma industry.
Destination India: Reconfiguring Gelatin Value Chain
Bovine Gelatin Industry Overview The global gelatin production in was thousand tons which is expected to grow at a CAGR of till Globally of gelatin is bovine bone based The yield conversion factor from bovine bone chips to gelatin is Bovine bone chips are widely used to manufacture pharmaceutical gelatin since it is more preferred due to its encapsulation properties and higher bl
Crippled by Cost? CMO Quo Vadis
Introduction The global CMO market is said to reach USD billion by Patent expiry of drugs stringent price regulations especially in Europe US to purchase drugs from pharma companies Government budget cuts for pharma RD these are the forces which are expected to reshape the future of pharma and the CMO industry At least manufacturing facilities owned by pharma companies were shut dow
Driving Transformation Through Integrated Multichannel Marketing
Background Over the last few years the pharmaceutical industry has undergone a dramatic transformation including LoE RD productivity challenges regulatory hurdles reimbursement pressures and changes in the macroeconomic environment Implementing JIT labeling and packaging process effectively can potential
Impact analysis of Just in Time packaging and labeling on clinical supply chain
Abstract Clinical supply chain is in intense pressure for better management due to factors like globalization of clinical trials and increase of triple blinded clinical studies Traditional supply chain practices dont allow room for flexibility in shipments for medication kits as they are packaged and labeled in central depot This has led to an increas
Large Molecule Bioanalysis- Outsourcing opportunities & Challenges
Sarika Khasnis Research Analyst Beroe Inc Abstract The trade group Pharma for large pharmaceuticals has announced that industry has more than biologics under development having different therapeutic area focus The biologics market is estimated to be approximately billion by with a gr
Orphan Drugs – Sourcing API from Emerging Markets
Vaishnavi Loganathan Research Analyst Beroe Inc Abstract The drugs which are developed for the treatment of rare diseases diseases which affect a very small population are called Orphan Drugs The Governments of various countries provide incentives and patent exclusivities in order to encourage orpha
M&As in Health Economics and Outcome Research Sourcing Implications
Satyam Mishra Research Analyst Beroe Inc Abstract Health Economics and Outcome Research HEOR function has gained wide acceptance due to the regulatory authorities demanding more data for proving drug effectiveness and payers requiring data for reimbursement Lesser barriers to entry resulted in a fra
Anti-counterfeiting – Technology
Sarabjeet Singh Sharad Senior Research Analyst Beroe Inc International free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs worldwide Almost of medicines representing close to billion globally are said to be illegal Around of products in the legal pharmaceutical supply chain in the developed world a
Pharma\'s New Worldview - Transforming R&D through Emerging Markets
To date research and development RD within the pharmaceutical industry has been dominated by a developedmarket perspective But as emerging markets change Pharmas worldview its time for drugmakers to fundamentally rethink how RD is done Over US billion worth of products will lose patent protection over the next decade And late stage failures and sa
Make your move: Taking Clinical Trials to the Best location
Should pharmaceutical companies augment their offshore strategies by performing some clinical trials in lowercost locations The short answer is yes Emerging markets offer faster time to market reduced costs and the same high quality that companies demand But which countries present the best opportunities China India and Russia top the list according to AT Kearneys Country Attractiveness Index for...
